tiprankstipranks
Trending News
More News >
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF

Innate Pharma SA (IPHYF) Revenue

Compare
27 Followers

Innate Pharma SA Revenue

Innate Pharma SA had a revenue of 12.35M in the quarter ending Jun 30, 2024, with -42.43%. This bring the company's revenue in the last twelve months to 44.51M, Increased -49.19%. In the fiscal year ending Dec 31, 2023, Innate Pharma SA had annual revenue of 51.90M with 4.56% growth.
Revenue (ttm)
44.51M
Revenue Growth
P/S Ratio
3.13
Revenue/Employee
$286,746
Employees
181
Market Cap
$162.60M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202351.90M2.26M+4.56%
Dec 31, 202249.64M37.53M+309.83%
Dec 31, 202112.11M-44.72M-78.69%
Dec 31, 202056.83M-12.14M-17.60%
Dec 31, 201968.97M-10.92M-13.67%
Dec 31, 201879.89M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis